Literature DB >> 10421062

Increased serum interleukin-15 levels in bullous skin diseases: correlation with disease intensity.

L D'Auria1, C Bonifati, P Cordiali-Fei, G Leone, M Picardo, M Pietravalle, B Giacalone, F Ameglio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10421062     DOI： 10.1007/s004030050421

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN： 0340-3696            Impact factor:   3.017


× No keyword cloud information.
  7 in total

1.  Aberrant overexpression of IL-15 initiates large granular lymphocyte leukemia through chromosomal instability and DNA hypermethylation.

Authors:  Anjali Mishra; Shujun Liu; Gregory H Sams; Douglas P Curphey; Ramasamy Santhanam; Laura J Rush; Deanna Schaefer; Lauren G Falkenberg; Laura Sullivan; Laura Jaroncyk; Xiaojuan Yang; Harold Fisk; Lai-Chu Wu; Christopher Hickey; Jason C Chandler; Yue-Zhong Wu; Nyla A Heerema; Kenneth K Chan; Danilo Perrotti; Jianying Zhang; Pierluigi Porcu; Frederick K Racke; Ramiro Garzon; Robert J Lee; Guido Marcucci; Michael A Caligiuri
Journal:  Cancer Cell       Date:  2012-11-13       Impact factor: 31.743

2.  Expression of the JAK/STAT Signaling Pathway in Bullous Pemphigoid and Dermatitis Herpetiformis.

Authors:  K Juczynska; A Wozniacka; E Waszczykowska; M Danilewicz; M Wagrowska-Danilewicz; J Wieczfinska; R Pawliczak; A Zebrowska
Journal:  Mediators Inflamm       Date:  2017-10-24       Impact factor: 4.711

3.  Th1/Th17-Related Cytokines and Chemokines and Their Implications in the Pathogenesis of Pemphigus Vulgaris.

Authors:  Rodolfo Pessato Timoteo; Marcos Vinicius da Silva; Camila Botelho Miguel; Djalma Alexandre Alves Silva; Jonatas Da Silva Catarino; Virmondes Rodrigues Junior; Helioswilton Sales-Campos; Carlo Jose Freire Oliveira
Journal:  Mediators Inflamm       Date:  2017-02-22       Impact factor: 4.711

4.  Elevated Serum Levels of Interleukin-15 in Pemphigus Vulgaris Patients: a Potential Therapeutic Target.

Authors:  Maedeh Kheirodin; Zohreh Tehranchinia; Yasaman Ketabi; Soheil Tavakolpour; Sahar Dadkhahfar; Masoomeh Faghankhani; Hassan Vahidnezhad; Nikoo Mozafari
Journal:  Dermatol Pract Concept       Date:  2022-07-01

5.  Modeling the pharmacokinetic-pharmacodynamic relationship of the monoclonal anti-macaque-IL-15 antibody Hu714MuXHu in cynomolgus monkeys.

Authors:  Wei J Pan; Hong Li; Jim J Xiao; Michelle J Horner; Herve N Lebrec; Eric A Butz; Arunan Kaliyaperumal; Tsui C Cheah; Robert C Ortiz; Samantha P Prokop; Sabina A Buntich; Babette M Boren; Suzanne T Wolford; Wayne H Tsuji; Larry C Wienkers; Kathleen Köck
Journal:  Pharmacol Res Perspect       Date:  2016-01-11

6.  High Index Values of Enzyme-Linked Immunosorbent Assay for BP180 at Baseline Predict Relapse in Patients With Bullous Pemphigoid.

Authors:  Hiroshi Koga; Kwesi Teye; Norito Ishii; Chika Ohata; Takekuni Nakama
Journal:  Front Med (Lausanne)       Date:  2018-05-09

Review 7.  Emerging Biomarkers and Therapeutic Strategies for Refractory Bullous Pemphigoid.

Authors:  Tong Zhou; Bin Peng; Songmei Geng
Journal:  Front Immunol       Date:  2021-08-24       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.